# SELLAS Life Sciences Group, Inc. (SLS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from SELLAS Life Sciences Group, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/SLS/mda/fy2025/): filed 2026-03-19; accession 0001390478-26-000003 (https://www.sec.gov/Archives/edgar/data/1390478/000139047826000003/sls-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/SLS/mda/fy2024/): filed 2025-03-20; accession 0001390478-25-000003 (https://www.sec.gov/Archives/edgar/data/1390478/000139047825000003/sls-20241231.htm)
- [FY 2023 MD&A](/company/SLS/mda/fy2023/): filed 2024-03-28; accession 0001390478-24-000004 (https://www.sec.gov/Archives/edgar/data/1390478/000139047824000004/sls-20231231.htm)
- [FY 2022 MD&A](/company/SLS/mda/fy2022/): filed 2023-03-16; accession 0001390478-23-000005 (https://www.sec.gov/Archives/edgar/data/1390478/000139047823000005/sls-20221231.htm)
- [FY 2021 MD&A](/company/SLS/mda/fy2021/): filed 2022-03-31; accession 0001390478-22-000006 (https://www.sec.gov/Archives/edgar/data/1390478/000139047822000006/sls-20211231.htm)

Back to /company/SLS/